The curtain is drawn for both natalizumab and fingolimod (FTY720): a new era of multiple sclerosis therapy has arrived. Weissert R Expert Rev Neurother. 2006 Nov; 6(11):1587-90. PMID: 17144774. Abstract CommentRecommendBookmarkWatch
